|
|
Volumn 94, Issue 18, 2002, Pages 1352-1353
|
|
Big business: When wall street and cancer research collide
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PACLITAXEL DERIVATIVE;
PACLITAXEL POLIGLUMEX;
CANCER PATIENT;
CANCER RESEARCH;
COMMERCIAL PHENOMENA;
CONFIDENTIALITY;
CONTROLLED STUDY;
DRUG COST;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG TARGETING;
HEALTH CARE ORGANIZATION;
HUMAN;
INTERNET;
LUNG CANCER;
MARKET;
MEDICAL ETHICS;
MEDICAL SPECIALIST;
NOTE;
ONCOLOGY;
OVARY CANCER;
POLICY;
PRIORITY JOURNAL;
PUBLICATION;
SIDE EFFECT;
|
|
EID: 0037130880
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.18.1352 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|